ARQT

ARQT R&D to Revenue

20.49%Fiscal year

Period ending:

ARQT FY R&D/Revenue%
ARQT FY R&D/Revenue5543.33%-593.93%
2017-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

ARQT r&d to revenue history

R&D spending as percentage of revenue. The available annual fiscal periods series contains 9 observations from Dec 31, 2017 to Dec 31, 2025.

Arcutis Biotherapeutics Inc R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
20.4884%
38.8823%
185.5098%
4,949.4031%
0%
0%
0%
0%
0%

Compare r&d to revenue

All ARQT financial metrics · ARQT stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.